Gefapixant Citrate is a pivotal API in Loncom Pharmaceutical's portfolio, addressing the pressing needs of chronic cough treatment. Our API is a testament to our innovative approach in respiratory therapy, providing a new avenue for patients seeking relief from persistent and refractory coughing.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
